DEA Gives Epidiolex Schedule V Treatment
At around $32,500 a year, Epidiolex is the newest and most expensive CBD ONLY drug on the market to treat severe epilepsy. Problem is, there is no THC in it, or anything else in the Cannabinoid toolbox. It is plant derived CBD (98%), but you apparently aren't to be trusted growing this at home. The DEA has offered this Schedule V designation to EPIDIOLEX, NOT to CBD. For existing CBD manufacturers, they offered a cryptic warning of sorts, saying that anything outside of Epidiolex is still a schedule 1 narcotic, THC or No THC.
Kyle Jaeger article:
DEA Entry into the Federal Register:
DEA Press Release about Epidiolex: